NR1D1 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-12-03. Numbers and descriptions here follow the published literature rather than marketing material.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine in major jurisdictions | Sold as a research chemical; legal status varies |
| Anti-doping status | Prohibited by the World Anti-Doping Agency | Listed under non-approved substances or related category |
| Typical analytical method | LC-MS/MS | Used for detection and confirmation in biological samples |
| Storage temperature | −20 °C or lower for solid | Desiccated and protected from light |
| Common solution solvents | DMSO; ethanol | Aqueous solubility is limited |
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
Frost-free refrigerators and freezers use electric fans to cool the appropriate compartment. This could be called a "fan forced" refrigerator, whereas manual defrost units rely on colder air lying at the bottom, versus the warm air at the top to achieve adequate cooling. The air is drawn in through an inlet duct and passed through the evaporator where it is cooled, the air is then circulated throughout the cabinet via a series of ducts and vents. Because the air passing the evaporator is supposedly warm and moist, frost begins to form on the evaporator (especially on a freezer's evaporator). In cheaper and/or older models, a defrost cycle is controlled via a mechanical timer. This timer is set to shut off the compressor and fan and energize a heating element located near or around the evaporator for about 15 to 30 minutes at every 6 to 12 hours. This melts any frost or ice build-up and allows the refrigerator to work normally once more. It is believed that frost free units have a lower tolerance for frost, due to their air-conditioner-like evaporator coils. Therefore, if a door is left open accidentally (especially the freezer), the defrost system may not remove all frost, in this case, the freezer (or refrigerator) must be defrosted. If the defrosting system melts all the ice before the timed defrosting period ends, then a small device (called a defrost limiter) acts like a thermostat and shuts off the heating element to prevent too large a temperature fluctuation, it also prevents hot blasts of air when the system starts again, should it finish defrosting early.
The Ms. Pat Show is an American television sitcom created by Jordan E. Cooper and Patricia "Ms. Pat" Williams that premiered on the streaming service BET+ on August 12, 2021. The show is based on the comedy and life story of comedian Ms. Pat as a convicted felon from the streets of Atlanta turned reluctant suburban mother. The series has received nominations for 4 Primetime Emmy Awards for Outstanding Directing for a Comedy Series.
Buffalo General Medical Center-Located on the Buffalo Niagara Medical Campus, Buffalo General Medical Center offers a wide spectrum of clinical inpatient and outpatient treatment programs. John R. Oishei Children's Hospital-This regional center for specialized pediatric and women's health care has achieved national recognition and is ranked among the top 20 pediatric hospitals in the nation by U.S. News & World Report. Millard Fillmore Suburban Hospital- this 200-bed community hospital supports residency training programs in anesthesiology, emergency medicine, general surgery, urology, obstetrics and gynecology, and family practice. DeGraff Memorial Hospital-A 70-bed community hospital primarily serving the needs of patients in towns north of Buffalo. Erie County Medical Center-This 550-bed medical center serves as a regional center for trauma, burns, rehabilitation and cardiac care. Veterans Affairs Western New York Healthcare System-The Buffalo VA Medical Center provides inpatient and outpatient programs. It is the main referral center for cardiac surgery, cardiology and comprehensive cancer care for Western New York and northern Pennsylvania. Sisters of Charity Hospital- Buffalo's first hospital and a Designated Stroke Center, Sisters of Charity Hospital serves patients in its inpatient and outpatient facilities. Mercy Hospital of Buffalo-Mercy Hospital is a Center of Excellence for Stroke and Cardiac Care. It recently revamped emergency department is a model for emergency health-care treatment.
Sources: en.wikipedia.org
Animals have several characteristics that they share with other living things. Animals are eukaryotic, multicellular, and aerobic, as are plants and fungi. Unlike plants and algae, which produce their own food, animals cannot produce their own food, a feature they share with fungi. Animals ingest organic material and digest it internally.
Thoracic outlet syndrome Arterial rupture Valvular heart disease, such as mitral valve prolapse, creates an increased risk for infective endocarditis during surgery. This may progress to a life-threatening degree. Heart conduction abnormalities have been found in those with hypermobility form of EDS. Dilation (aneurysm) or rupture (dissection) of ascending aorta Cardiovascular autonomic dysfunction such as postural orthostatic tachycardia syndrome Raynaud's phenomenon Varicose veins Heart murmur Heart conduction abnormalities
== Timing and re-epithelialization == Timing is important to wound healing. Critically, the timing of wound re-epithelialization can decide the outcome of the healing. If the epithelization of tissue over a denuded area is slow, a scar will form over many weeks, or months; If the epithelization of a wounded area is fast, the healing will result in regeneration.
Sources: en.wikipedia.org
Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.
Laboratories typically use LC-MS/MS to detect SR9009 and related compounds in urine or blood. The method is sensitive but depends on sample collection timing. Confirmatory analysis follows quality-control procedures.
Solid material is generally kept cold, dry, and protected from light. Solutions are often stored in sealed containers at low temperature. Stability beyond recommended periods is not well documented.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.